M84.552S Pathological fracture in neoplastic disease, left femur, sequela

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Left Femur, Sequela (ICD-10-CM: M84.552S)

Summary

This condition describes a pathological fracture of the left femur resulting from underlying neoplastic disease, with the "sequela" modifier indicating residual effects following the acute phase of the fracture. The fracture occurs due to weakened bone structure caused by cancer, rather than direct trauma, and represents a complication of malignancy affecting the femur. It may involve primary bone tumors or metastatic spread to this skeletal region, with lasting consequences after the initial injury has healed.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the left femur, compromising its structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode the femur, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone, resulting in a fracture that persists as a sequela.

Risk Factors

• History of cancer, particularly with known bone metastasis to the left femur.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to femoral sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Chronic pain or discomfort in the left femur.
• Reduced mobility or functional impairment.
• Visible deformity or instability in the affected limb.
• Persistent swelling or tenderness at the fracture site.
• Difficulty bearing weight on the left leg.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies, and correlation with the patient’s cancer history. X-rays or CT scans of the left femur may reveal the fracture and associated bone changes. MRI or bone scans can assess tumor involvement and healing status. Biopsy or prior cancer documentation may confirm the neoplastic cause. The sequela modifier is applied when the fracture has healed but residual effects (e.g., chronic pain, deformity) persist.

Treatment Options

Treatment focuses on managing symptoms and addressing underlying cancer. Pain management, physical therapy, and mobility aids (e.g., braces, walkers) may improve function. For persistent instability, surgical intervention (e.g., fixation, reconstruction) could be considered. Oncologic care, including chemotherapy or radiation, targets the primary malignancy to prevent further bone damage.

Prognosis and Follow-Up

Prognosis depends on the extent of bone damage, cancer type, and response to treatment. Sequelae like chronic pain or mobility issues may persist long-term. Regular follow-up with oncology and orthopedic specialists is essential to monitor healing, manage symptoms, and address any recurrence or complications. Imaging and functional assessments guide ongoing care.

Complications

• Chronic pain or persistent instability in the left femur.
• Reduced mobility or disability.
• Increased risk of future fractures due to ongoing bone weakness.
• Potential for tumor progression affecting the femur.
• Psychological impact from chronic symptoms or functional limitations.

Lifestyle & Prevention

• Engage in gentle, low-impact exercise to maintain mobility, as tolerated.
• Use assistive devices (e.g., canes, walkers) to reduce strain on the left femur.
• Follow oncologic treatment plans to control cancer and minimize bone damage.
• Maintain a balanced diet with adequate calcium and vitamin D to support bone health.
• Avoid high-impact activities that could exacerbate residual weakness.

When to Seek Professional Help

Seek immediate care if new or worsening pain, swelling, or deformity occurs in the left femur, as these may indicate a new fracture or tumor progression. Contact a healthcare provider for persistent mobility issues, unmanaged pain, or signs of infection (e.g., redness, fever) at the fracture site.

Tips for Medical Coders

Document the sequela status clearly, indicating that the fracture has healed but residual effects (e.g., chronic pain, deformity) persist. Include details on the underlying neoplastic disease and its relationship to the fracture. Ensure the "sequela" modifier (S) is applied appropriately to reflect the post-acute phase of care. Corroborate with clinical notes to confirm the fracture’s history and current impact on function.